🔎 Trials Near Me

Utama › Mielofibrosis › Michigan

Kajian klinikal Mielofibrosis di Michigan

10 kajian untuk Mielofibrosis sedang mencari peserta di lokasi di Michigan.

Bandar di Michigan

Teks kajian rasmi (Bahasa Inggeris)

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

  • University of Michigan, Ann Arbor
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04176198

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

  • START Midwest, LLC, Grand Rapids
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07469891

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

  • University of Michigan, Ann Arbor
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT05320198

Quantitative MRI for Myelofibrosis

  • University of Michigan Hospital, Ann Arbor
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 99 · Semua jantina · Dikemas kini 31 Jul 2026 · NCT01973881

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

  • GSK Investigational Site, Ann Arbor
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Apr 2026 · NCT06517875

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

  • University of Michigan ( Site 6000), Ann Arbor
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Apr 2026 · NCT06351631

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Ann Arbor
  • Massive Bio SYNERGY-AI site, Lansing
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

  • University of Michigan Hospital, Ann Arbor
  • Henry Ford Cancer Institute - Brigitte Harris Cancer Pavilion, Detroit
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2025 · NCT06479135

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.